Roelof W. F. van Leeuwen

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

Roelof W. F. van Leeuwen, Daniel H.S. Brundel, Cees Neef et al. · British Journal of Cancer · 2013 · 264 citations · Full text

Medicine, Oncology, Pharmacology +17

Drug–drug interactions in patients treated for cancer: a prospective study on clinical interventions

Roelof W. F. van Leeuwen, Frank G. A. Jansman, Patricia M. L. A. van den Bemt et al. · Annals of Oncology · 2015 · 142 citations · Full text

Medicine, Oncology, Pharmacology +16

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method

Roelof W. F. van Leeuwen, Eleonora L. Swart, E. Boven et al. · Annals of Oncology · 2011 · 138 citations

Medicine, Oncology, Pharmacology +16

Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules

Guoying Zhou, Dave Sprengers, Shanta Mancham et al. · Journal of Hepatology · 2019 · 127 citations

Medicine, Immunology, Oncology +16

Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non–Small-Cell Lung Cancer

Roelof W. F. van Leeuwen, Robert Peric, Koen G. A. M. Hussaarts et al. · Journal of Clinical Oncology · 2016 · 116 citations

Pharmacy, Pharmacokinetics, Pharmacology +16